Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: Case report and review of the literature

References

• Heim S, Avanzi G C, Billstrom R, Kristoffersson U, Mandahl N, Bekassy A N, et al. A new specific chromosomal rearrangement, t(8;16) (p11;p13), in acute monocytic leukaemia. British Journal of Haematology 1987; 66: 323–326
   PubMed Web of Science ®Google Scholar
• Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)—case report and review of the literature. Leukemia Research 1995; 19: 367–379
   PubMed Web of Science ®Google Scholar
• Velloso E R, Mecucci C, Michaux L, Van Orshoven A, Stul M, Boogaerts M, et al. Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature. Leukemia & Lymphoma 1996; 21: 137–142
   PubMed Web of Science ®Google Scholar
• Sun T, Wu E. Acute monoblastic leukemia with t(8;16): a distinct clinicopathologic entity; report of a case and review of the literature. American Journal of Hematology 2001; 66: 207–212
   PubMed Web of Science ®Google Scholar
• Hui C H, Suttle J. Erythrophagocytosis associated with AML-M5 and t(8;16). British Journal of Haematology 2001; 113: 845
   PubMed Web of Science ®Google Scholar
• Bernstein R, Pinto M R, Spector I, Macdougall L G. A unique 8;16 translocation in two infants with poorly differentiated monoblastic leukemia. Cancer Genetics & Cytogenetiucs 1987; 24: 213–220
   PubMed Web of Science ®Google Scholar
• Juneja H S, Elder F F, Rajaraman S. Acute monoblastic leukemia with a single chromosomal rearrangement involving breakpoints on chromosomes 8 and 16, 46, XX, t(8;16)(p11;p13). Acta Haematologica 1987; 78: 1–5
   PubMed Web of Science ®Google Scholar
• Cleary B, Binder R A, Kales A N, Veltri B J. Simultaneous presentation of acute myelomonocytic leukemia and multiple myeloma. Cancer 1978; 41: 1381–1386
   PubMed Web of Science ®Google Scholar
• Annino L, Martino P, Barsotti P, Serra P, Marinozzi V, Mandelli F. Multiple myeloma and acute myelomonocytic leukemia: simultaneous occurrence without previous chemotherapy. Acta Haematologica 1980; 64: 195–200
   PubMed Web of Science ®Google Scholar
• Raz I, Polliack A. Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer 1984; 53: 83–85
   PubMed Web of Science ®Google Scholar
• Luca D C, Almanaseer I Y. Simultaneous presentation of multiple myeloma and acute monocytic leukemia. Archives of Pathology & Laboratory Medicine 2003; 127: 1506–1508
   PubMed Web of Science ®Google Scholar
• Strayer D S, Phillips G B, Herzig G, Bari W, Santa Cruz D J. Acute myelomonocytic leukemia presenting as a primary cutaneous lymphoma of true histiocytes. Journal of the American Academy of Dermatology 1982; 7: 229–235
   PubMed Web of Science ®Google Scholar
• Laurencet F M, Chapuis B, Roux-Lombard P, Dayer J M, Beris P. Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?. Leukemia 1994; 8: 502–506
   PubMed Web of Science ®Google Scholar
• Esteve J, Rozman M, Campo E, Munoz F, Urbano-Ispizua A, Rozman C. Leukemia after true histiocytic lymphoma: another type of acute monocytic leukemia with histiocytic differentiation (AML-M5c)?. Leukemia 1995; 9: 1389–1391
   PubMed Web of Science ®Google Scholar
• Murashige N, Tabanda R, Zalusky R. Occurrence of acute monocytic leukemia in a case of untreated Waldenstrom's macroglobulinemia. American Journal of Hematology 2002; 71: 94–97
   PubMed Web of Science ®Google Scholar
• Padmanabhan V, Trainer T D. Synchronous adenocarcinoma and mantle cell lymphoma of the colon. Archives of Pathology and Laboratory Medicine 2003; 127: E64–E66
   PubMedGoogle Scholar
• Tinguely M, Rosenquist R, Sundstrom C, Amini R M, Kuppers R, Hansmann M L, et al. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center. American Journal of Surgical Pathology 2003; 27: 1483–1488
   PubMed Web of Science ®Google Scholar
• Rozman M, Camos M, Colomer D, Villamor N, Esteve J, Costa D, et al. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes & Chromosomes in Cancer 2004; 40: 140–145
   PubMed Web of Science ®Google Scholar
• Schmidt H H, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W, et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004; 18: 1115–1121
   PubMed Web of Science ®Google Scholar
• Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. 2004, [Internet]. Available online at: http://cgap.nci.nih.gov/Chromosomes/Mitelman, accessed 21 September 2004
   Google Scholar
• Block A W, Carroll A J, Hagemeijer A, Michaux L, van Lom K, Olney H J, et al. Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes & Chromosomes in Cancer 2002; 33: 401–412
   PubMed Web of Science ®Google Scholar
• Fisher S G, Fisher R I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004; 23: 6524–6534
   PubMed Web of Science ®Google Scholar
• Smith R E, Bryant J, DeCillis A, Anderson S. National surgical adjuvant breast and bowel project experience. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the national surgical adjuvant breast and bowel project experience. Journal of Clinical Oncology 2003; 21: 1195–1204
   PubMed Web of Science ®Google Scholar
• Obedian E, Fischer D B, Haffty B G. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. Journal of Clinical Oncology 2000; 18: 2406–2412
   PubMed Web of Science ®Google Scholar
• Levine E G, Bloomfield C D. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Seminars in Oncology 1992; 19: 47–84
   PubMed Web of Science ®Google Scholar
• Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Molecular Pathology 1998; 51: 1–7
   PubMedGoogle Scholar
• Costea I, Moghrabi A, Krajinovic M. The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenetics 2003; 9: 577–580
   Google Scholar
• Bosch F, Campo E, Jares P, Pittaluga S, Munoz J, Nayach I, et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. British Journal of Haematology 1995; 91: 1025–1030
   PubMed Web of Science ®Google Scholar
• de Boer C J, Kluin-Nelemans J C, Dreef E, Kester M G, Kluin P M, Schuuring E, et al. Involvement of the CCND1 gene in hairy cell leukemia. Annals of Oncology 1996; 7: 251–256
   PubMed Web of Science ®Google Scholar
• Sauerbrey A, Hafer R, Zintl F, Volm M. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Research 1999; 19: 645–649
   PubMed Web of Science ®Google Scholar
• Chen F, Studzinski G P. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Experimental Cell Research 1999; 249: 422–428
   PubMed Web of Science ®Google Scholar
• Chen F, Rao J, Studzinski G P. Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells. Journal of Leukocyte Biology 2000; 4: 559–566
   Google Scholar
• Chen F, Studzinski G P. Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 2001; 97: 3763–3767
   PubMed Web of Science ®Google Scholar
• Studzinski G P, Harrison J S. The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells. Leukemia & Lymphoma 2003; 44: 235–240
   PubMed Web of Science ®Google Scholar
• Chevallier N, Corcoran C M, Lennon C, Hyjek E, Chadburn A, Bardwell V J, et al. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood 2004; 103: 1454–1463
   PubMed Web of Science ®Google Scholar
• Capello D, Vitolo U, Pasqualucci L, Quattrone S, Migliaretti G, Fassone L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95: 651–659
   PubMed Web of Science ®Google Scholar
• Chaganti S R, Chen W, Parsa N, Offit K, Louie D C, Dalla-Favera R, et al. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes & Chromosomes in Cancer 1998; 23: 323–327
   PubMed Web of Science ®Google Scholar